Manar G. Helal (2019) “Empagliflozin attenuates cyclophosphamide-induced hepatotoxicity via targeting Nrf2/HO-1 signaling, oxidative stress, and inflammation”, World Journal of Pharmaceutical Sciences, 7(11), pp. 49–59. Available at: https://www.wjpsonline.com/index.php/wjps/article/view/empagliflozin-attenuates-cyclophosphamide-induced-hepatotoxicity (Accessed: 27 June 2025).